Zymeworks (ZYME) Other Non Operating Income (2021 - 2022)
Zymeworks (ZYME) posted Other Non Operating Income of $1.4 million for Q3 2022, up 67.86% sequentially from $809000.0 in Q3 2021, and up 67.86% YoY from $809000.0 in Q3 2021.
Powered by 
Analysis
Zymeworks (ZYME) Other Non Operating Income (2021 - 2022) Analysis & Trends
Zymeworks has reported Other Non Operating Income for 2 years, with the latest figure at $1.4 million in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.14 Bn | 1.87 Bn | - |